Grimm g e g (64 Ergebnisse)

Hardcover. Zustand: Rück. teils beschabt,Vors. U. 352 Ss m. 10 montierten Porträts.OLn.

2 Bde. Kl.-8°. Mit Illustr. 475; 520 S. Farb. illustr. OPappbde. i. farb. illustr. OKt.-Schuber. - Universal-Bibliothek, 8462-8463. - Gutes Ex. * Bd. 1: Erzählungen v.d. Romantik bis z.Gegenwart. Bd. 2: Gedichte v.d. Klassik bis zur Gegenwart. 1.

414, (2) S., OBrosch. (stellenw. verblaßt). Sonst gutes Exemplar. EA.

brossura. Zustand: condizioni quasi ottime. Collana Rosa d'oro. Libera versione di Laura Okely Romiti. A colori. Legatura punto metallico. Formato in.8 (24x22 cm). Pagg. n.n. (24). Dedica a penna al frontespizio. Lievi segni. Ottimo stato.

brossura. Zustand: condizioni quasi ottime. Collana Rosa d'oro. A colori. Legatura punto metallico. Formato in.8 (24x22 cm). Pagg. n.n. (24). Quartino centrale staccato. Lievi segni. Ottimo stato.

xlii, 669 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

In-8° pp. 112 con 4 tav. f.t. e la copertina in mezza tela edit. con ill. a colori applicata al piatto di Scarpelli.

In-8° pp. 110 con 4 tav. f.t. e i fogli di guardia ill. da Bruno da Osimo. Legatura in mezza tela edit. ill. a colori con gore ininfluenti.

18 pp., 2 figs, gr. 8.

München, Beck, 1975. 414 pp. Paperback. Bibliography. (ALU) *cover a bit discoloured, bookblock lightly foxed, otherwise good condition*.

paperback. Zustand: Good. Ship out in 2 business day, And Fast shipping, Free Tracking number will be provided after the shipment.Seven of the Complete Works of the Brothers Grimm Clever Little TailorFour Satisfaction guaranteed,or money back.

paperback. Zustand: Good. Ship out in 2 business day, And Fast shipping, Free Tracking number will be provided after the shipment.Six of the Complete Works of the Brothers Grimm fairy glass.Four Satisfaction guaranteed,or money back.

Zustand: As New. Unread book in perfect condition.

Zustand: 8 tavole b.n. f.t. di C.Sarri. pp. 224 16° ril. edit. mezza tela, titolo oro al dorso, piatto illustrato da R.Sgrilli.

Zustand: DISCRETO USATO. Da revisionare ITALIANO Scelta dall'opera originale: Bruder Grimm, Kinder- und Hausmaerchen, traduzione a cura di Dante Virgili. Legatura in similpelle imbottita al piatto anteriore, con titoli in giallo in copertina ed al dorso, leggermente scollata al piatto posteriore ( quest'ultimo senza imbottitura) e completamente distaccata dal dorso. Scotch alle controgardie e piccola mancanza all' angolo superiore della controguardia anteriore . Tagli ingialliti e con piccole fioriture; pagine appena ingiallite, con ampio margine e legatura poco allentata, corredate da alcune tavole a colori fuori testo. Fioriture sparse e scotch al margine inferiore della pagina 69 ad unire uno strappetto. Numero pagine 185. …

NRF / Gallimard / Pléiade Paris, 1989, in-12 reliure cuir éditeur sous rhodoïd et boitier illustré. XLII-pp.-1744pp. Introduction par Erika Turner. Notices et notes par Jean-Claude Schneider. Contient : Bonaventura : Les Veilles / C. Brentano : Godwi (extraits) ; La chronique de l'écolier itinérant ; la demoiselle au myrte ; Raimondin ; Histoire du brave Gaspard et de la belle Annette ; Gockel./ Bettina et Achim von Arnim : Correspondance de goethe avec une enfant ; Contes / Grimm : contes de l'enfance et du foyer / J. von Eichendorff : la statue de marbre ; scènes de la vie d'un propre à rien / A. von Chamisso : Pierre Schlémihl ou l'homme qui a perdu son ombre / J. Kerner : les apatrides / E. Mörike : Le peintre Nolten / G. Büchner : Lenz. Très bon état.…

hardcover. Zustand: Very Good. The copy shows minor external wear, but is otherwise in clean condition.

Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Zustand: New.

Gebunden. Zustand: New.

Taschenbuch. Zustand: Neu. Retinal Degenerative Diseases | Mechanisms and Experimental Therapy | John D. Ash (u. a.) | Taschenbuch | lxi | Englisch | 2016 | Springer | EAN 9781493952762 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Taschenbuch. Zustand: Neu. Retinal Degenerative Diseases | Mechanisms and Experimental Therapy | John D. Ash (u. a.) | Taschenbuch | Advances in Experimental Medicine and Biology | xlii | Englisch | 2019 | Springer | EAN 9783030092214 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Zustand: New. pp. 932.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.…

Zustand: Hervorragend. Zustand: Hervorragend | Seiten: 616 | Sprache: Englisch | Produktart: Bücher | This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the ¿best¿ and ¿most important¿ meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes,cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium, RD2016. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2014. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2018 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.…

Gebunden. Zustand: New.

Zustand: As New. Unread book in perfect condition.